Synonyms: ARV-110 | ARV110 | compound 406 [WO2018071606A1]
Compound class:
Synthetic organic
Comment: Bavdegalutamide (ARV110) is a bifunctional degarder class compound (PROTAC). One end of the molecule binds to the androgen receptor and the other binds to the cereblon E3 ligase and directs the AR for proteasome-mediated degradation [1]. It has clinical potential as an oral therapy for metastatic castration-resistant prostate cancer. PubChem CID 134414307 represents the molecule without specified stereo chemistry.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Ligand families/groups | PROTACs, molecular glues and other degraders |
International Nonproprietary Names ![]() |
|
INN number | INN |
11542 | bavdegalutamide |
Synonyms ![]() |
ARV-110 | ARV110 | compound 406 [WO2018071606A1] |
Database Links ![]() |
|
GtoPdb PubChem SID | 441604884 |
PubChem CID | 134414307 |
Search Google for chemical match using the InChIKey | CLCTZVRHDOAUGJ-SYVGMNBRSA-N |
Search Google for chemicals with the same backbone | CLCTZVRHDOAUGJ |
Search PubMed clinical trials | bavdegalutamide |
Search PubMed titles | bavdegalutamide |
Search PubMed titles/abstracts | bavdegalutamide |
UniChem Compound Search for chemical match using the InChIKey | CLCTZVRHDOAUGJ-SYVGMNBRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | CLCTZVRHDOAUGJ-SYVGMNBRSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Bavdegalutamide (links to external site)
Cat. No. HY-138641 |